2 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Not yet recruiting 1 |
Follow NK042: new trials by email Literature Review of NK042 trials Research Report on NK042
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS). NK042, ofatumumab - Multiple Sclerosis | Early Phase 1 | Not yet recruiting | The Affiliated Hospital of Xuzhou Medical University | 20 | 2026-05-01 | 2026-04-22 |
| A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors NK042, Fludarabine (FLU), Cyclophosphamide (CTX) - Advanced Solid Tumors | Phase 1 | Recruiting | Shanghai NK Cell Technology Co., LTD | 76 | 2025-02-07 | 2026-04-06 |
| A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites NK042 - Gynecologic Cancer | Phase 1 | Not yet recruiting | Anhui Provincial Hospital | 9 | 2024-05-06 | 2024-05-16 |
Anhui Provincial Hospital (1) · Shanghai NK Cell Technology Co., LTD (1) · The Affiliated Hospital of Xuzhou Medical University (1)
China (2)
Fudong Shi, MD (1) · Guiyun Cui, MD (1) · Ying Zhou, MD (1) · Yong Zhang, MD (1)